Literature DB >> 9374441

Muscarinic receptor stimulation increases tolerance of rat salivary gland function to radiation damage.

R P Coppes1, A Vissink, L J Zeilstra, A W Konings.   

Abstract

PURPOSE: To investigate if muscarinic receptor-stimulated activation of the PLC/PIP2 second messenger pathway prior to irradiation increases the radiotolerance of rat salivary gland.
MATERIALS AND METHODS: Rats were treated with pilocarpine, methacholine, reserpine, methacholine plus reserpine, or atropine prior to irradiation with a single dose of 15 Gy X-rays. Parotid and submandibular/sublingual saliva was collected 4 days before and 1-30 days after irradiation. Lag phase, flow rate, amylase secretion, and salivary sodium and potassium concentration were measured.
RESULTS: Pretreatment with pilocarpine or methacholine resulted in an improvement of all measured functions of both glands. Pretreatment with reserpine had no effect on parotid gland function. Reserpine plus methacholine did not increase parotid gland function when compared with methacholine alone, indicating a purely muscarinic receptor stimulation as the initiator for the induced radioprotection. Pretreatment protective effects on submandibular gland function of reserpine plus methacholine were additive, indicating cooperation of muscarinic and alpha-adrenergic receptors. Atropine pretreatment slightly increased the radiation induced loss of salivary gland function.
CONCLUSIONS: Preirradiation activation of PLC/PIP2 second messenger pathway through stimulation of muscarinic receptors reduces the salivary gland radiosensitivity. The observed protection of salivary gland function may be of a secondary nature, implicating a cell conditioning after receptor stimulation of the PLC/PIP2 pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9374441     DOI: 10.1080/095530097143112

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  7 in total

1.  The protective effects of different treatments on rat salivary glands after radiotherapy.

Authors:  Murat Konak; Hakan Cincik; Evren Erkul; Zafer Kucukodaci; Atila Gungor; Sevim Ozdemir; Engin Cekin; Volkan Arisan; Mesut Mutluoglu; Murat Salihoglu
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-20       Impact factor: 2.503

2.  MDM2 is required for suppression of apoptosis by activated Akt1 in salivary acinar cells.

Authors:  Kirsten H Limesand; Kathryn L Schwertfeger; Steven M Anderson
Journal:  Mol Cell Biol       Date:  2006-09-18       Impact factor: 4.272

3.  Pharmacological prevention of radiation-induced dry eye-an experimental study in a rabbit model.

Authors:  Julia Beutel; Christina Schroder; Katharina von Hof; Dirk Rades; Hartwig Kosmehl; Thilo Wedel; Peter Sieg; Gerd Geerling; Samer George Hakim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02-21       Impact factor: 3.117

4.  Restoration of radiation therapy-induced salivary gland dysfunction in mice by post therapy IGF-1 administration.

Authors:  Oliver Grundmann; Jamia L Fillinger; Kerton R Victory; Randy Burd; Kirsten H Limesand
Journal:  BMC Cancer       Date:  2010-08-10       Impact factor: 4.430

5.  Defects in muscarinic receptor-coupled signal transduction in isolated parotid gland cells after in vivo irradiation: evidence for a non-DNA target of radiation.

Authors:  R P Coppes; A Meter; S P Latumalea; A F Roffel; H H Kampinga
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640

6.  Early to late sparing of radiation damage to the parotid gland by adrenergic and muscarinic receptor agonists.

Authors:  R P Coppes; L J Zeilstra; H H Kampinga; A W Konings
Journal:  Br J Cancer       Date:  2001-09-28       Impact factor: 7.640

7.  Salidroside Ameliorates Radiation Damage by Reducing Mitochondrial Oxidative Stress in the Submandibular Gland.

Authors:  Yue-Mei Sun; Xin-Yue Wang; Xin-Ru Zhou; Chong Zhang; Ke-Jian Liu; Fu-Yin Zhang; Bin Xiang
Journal:  Antioxidants (Basel)       Date:  2022-07-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.